The Arab Energy Fund and Stonepeak Enter $1 Billion Strategic Partnership to Advance Energy Infrastructure Across the Middle East
RIYADH, Saudi Arabia & NEW YORK--(BUSINESS WIRE)--The Arab Energy Fund (formerly APICORP), a leading multilateral impact financial institution focused on the MENA energy sector, and Stonepeak, the world's largest independent infrastructure firm and leading US infrastructure investor, today announced that they have entered into a strategic partnership to invest in energy infrastructure across the Middle East.
The partnership will primarily focus on businesses in the energy sector, supporting efforts to build critical infrastructure in the region.
'This strategic alliance marks a defining step in our mission to mobilize global capital into the region's evolving energy landscape,' said Khalid Ali Al-Ruwaigh, Chief Executive Officer of The Arab Energy Fund. 'With Stonepeak as a partner, we aim to accelerate the development of resilient, future-ready energy platforms that contribute to economic growth and energy security across the Middle East.'
'This partnership reinforces our long-term strategy to back high-quality energy assets in collaboration with experienced global investors,' said Maheur Mourali, Chief Investment Officer of The Arab Energy Fund. 'Stonepeak brings world-class expertise and alignment with our vision to deliver both impact and value through disciplined investment in essential infrastructure.'
'The Middle East has made energy diversification a key priority, with Saudi Arabia and other nations throughout the region setting ambitious targets,' said Mike Dorrell, CEO, Chairman, and Co-Founder of Stonepeak. 'We are thrilled to be partnering with The Arab Energy Fund to build and create businesses in the region focused on this mission-critical sector.'
'This partnership will support the continued growth and evolution of the region's energy sector,' added Hajir Naghdy, Senior Managing Director and Head of Asia and the Middle East at Stonepeak. 'With our local presence in the region and deep expertise in the global energy sector, Stonepeak is well-positioned to contribute meaningfully to this exciting partnership.'
About The Arab Energy Fund
The Arab Energy Fund is a multilateral impact financial institution focused on the MENA energy sector established in 1974 by the ten Arab oil-exporting countries. The Arab Energy Fund's mission is to enable a secure and sustainable energy future for the region through a comprehensive range of financing and direct equity solutions and expert advisory services across the entire energy value chain to leading public and private sector business partners in over 35 markets. The Arab Energy Fund applies best-practice ESG principles across all operations, with environmental and socially linked projects comprising 20% of its USD 5.8bn loan portfolio. The Arab Energy Fund is the only energy-focused financial institution in the MENA region rated 'Aa2' by Moody's, 'AA' by Fitch and 'AA-' by S&P.
About Stonepeak
Stonepeak is a leading alternative investment firm specializing in infrastructure and real assets with approximately $73 billion of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, with a focus on downside protection and strong risk-adjusted returns. Stonepeak, as sponsor of private equity and credit investment vehicles, provides capital, operational support, and committed partnership to grow investments in its target sectors, which include digital infrastructure, energy and energy transition, transport and logistics, and real estate. Stonepeak is headquartered in New York with offices in Houston, Washington, D.C., London, Hong Kong, Seoul, Singapore, Sydney, Tokyo, Abu Dhabi, and Riyadh. For more information, please visit www.stonepeak.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Bitcoin climbs as companies increasingly use tokens to 'hedge against inflation'
Bitcoin (BTC-USD) climbed toward a new high on Tuesday as investors continue to bet on the Trump administration's friendly stance toward the crypto industry and companies increasingly add the token to their balance sheets. As of 1 pm ET, the token was trading just below $109,000, roughly $3,000 away from touching its all-time intraday high in May. Greater adoption of the token has been driven in part by dozens of public companies getting on the bitcoin bandwagon. "Over time, bitcoin has proven itself to be a better hedge against inflation than many other asset classes," said Elliot Johnson, CEO of Bitcoin Treasury Corp., an advisory firm that helps companies acquire and hold bitcoin as part of their balance sheets. Johnson points out over the past five years, bitcoin is up over 1,000% while gold has returned about 92.5%. "Meanwhile, the US dollar has lost more than 20% of its value over the last five years due to inflation," said Johnson. However, the strategy spearheaded by Strategy and copied by dozens of companies, carries risks. 'The main risk in running a leveraged 'bitcoin treasury' strategy is that a rapid drop in the price of bitcoin would lead to a possibility of bankruptcy,' NYU Stern School of Business professor David Yermack told Yahoo Finance in a recent interview. On Monday, shares of bitcoin juggernaut Strategy (MSTR) jumped more than 4% after the company said it purchased 1,045 more tokens from June 2 to June 8, with total holdings now worth more than $62 billion, according to Bloomberg data. But 'MSTR's scale is hard to replicate,' Bernstein analyst Gautam Chhugani wrote in a May note. 'Not every Bitcoin treasury will be successful simply replicating MSTR's playbook, in our view.' Trump Media & Technology Group (DJT) shares fell more than 10% during one session in May after the Trump-backed company announced plans to create what it claims will be one of the largest bitcoin treasuries held by any public company. GameStop (GME) stock also slid nearly 25% immediately after the company announced in March it would raise $1.3 billion to buy bitcoin. Around 80 companies have adopted the so-called "bitcoin standard" by adding the token to their balance sheets. Corporates now hold roughly 3.4% of all tokens in circulation, according to Bernstein analysis. "Bitcoin is great, we love it and still believe $200K is our high-conviction but conservative price forecast this cycle," wrote Bernstein's Chhugan on Monday. The cryptocurrency is up more than 55% since President Trump, who promised a crypto-friendly framework, was elected last November. Trump's first order of business when he reentered the White House included the placement of a crypto-friendly advocate to head the Securities and Exchange Commission, and appointing a crypto-czar. Legislation in the Congress — which if passed, would regulate stablecoins, or digital assets backed by the US dollar — has lifted optimism over the crypto space. Senate Republicans are aiming to pass the bill this week. Click here for in-depth analysis of the latest stock market news and events moving stock prices Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Multi-Blood Monitoring System Market is expected to reach USD 3.9 billion by 2034, with a 6.4% CAGR growth
Multi Blood Monitoring System Market Overview 2025-2034 Luton, Bedfordshire, United Kingdom, June 10, 2025 (GLOBE NEWSWIRE) -- The global multi blood monitoring system market is witnessing dynamic expansion, with its value estimated at approximately USD 2.1 billion in 2024, and expected to grow to around USD 3.9 billion by 2034. This translates into a Compound Annual Growth Rate (CAGR) of 6.4% over the forecast period from 2025 to 2034. This growth is primarily fueled by the increasing demand for accurate, efficient, and accessible blood monitoring technologies across various healthcare applications. Download PDF Brochure: These devices are critical in the management of chronic diseases such as diabetes and cardiovascular conditions. As the global burden of such illnesses escalates, particularly among aging populations and across developing regions, the need for real-time, portable, and user-friendly blood monitoring systems has become more urgent than ever. Market Drivers and Opportunities Several underlying factors are contributing to the expansion of this market. Among the most significant drivers is the rising prevalence of chronic diseases. The World Health Organization (WHO) forecasts that by 2030, chronic diseases will account for over 75% of global deaths, highlighting the growing necessity for continuous and reliable health monitoring tools. Moreover, technological advancements in wearable devices, mobile health apps, and telemedicine have revolutionized the way blood monitoring is conducted. These innovations have led to more personalized and preventive healthcare solutions, allowing patients to self-monitor in real-time, often without the need for clinical supervision. This trend is particularly appealing to tech-savvy consumers and younger demographics who are increasingly proactive about their health. Emerging economies also present significant growth potential. With rising healthcare expenditure, expanding middle-class populations, and improving medical infrastructure, regions such as Asia-Pacific, Latin America, and parts of the Middle East are becoming fertile grounds for market expansion. Additionally, the integration of AI and machine learning into monitoring systems is creating opportunities for predictive diagnostics and tailored treatment strategies, revolutionizing the future of personalized medicine. Key Market Challenges Despite its positive growth outlook, the multi blood monitoring system market faces certain challenges. One of the primary obstacles is the complex regulatory landscape. Medical device manufacturers must navigate stringent approval processes, especially in developed regions like North America and Europe. These regulations, although necessary for ensuring safety and efficacy, often delay product rollouts and increase development costs. Supply chain disruptions have also impacted the market, particularly during and after the COVID-19 pandemic. Delays in procuring raw materials, component shortages, and transportation hurdles have affected production timelines and product availability. Furthermore, high costs associated with technologically advanced blood monitoring devices can be a deterrent for adoption, especially in price-sensitive markets. Healthcare providers are often pressured to deliver cost-effective solutions, which can limit investments in premium monitoring systems. Another pressing concern is data security and patient privacy. With the growing digitalization of healthcare and increased reliance on cloud-based data storage, ensuring the protection of sensitive patient information has become paramount. Regulatory frameworks such as HIPAA and GDPR are placing additional burdens on companies to fortify their cybersecurity measures. Market Segmentation Analysis By Product Type The market is segmented into several product categories including continuous glucose monitoring (CGM) systems, blood pressure monitors, cholesterol testing devices, and complete blood count (CBC) test devices. Among these, CGM systems are emerging as the dominant product category, accounting for roughly 35% of market share. The increased prevalence of diabetes globally has significantly contributed to this trend. Blood pressure monitoring devices come in second, capturing an estimated 25% of the market, owing to the widespread incidence of hypertension. Cholesterol testing devices follow with a 15% market share, as more individuals become aware of the risks associated with high cholesterol levels. By End User Hospitals are the largest consumers of multi blood monitoring systems, accounting for nearly 45% of the market share. The growing number of patients and a strong focus on preventive healthcare are driving demand in this segment. Diagnostic laboratories represent the second-largest user group, contributing 30% of market revenue, largely due to the complexity and volume of testing they handle. Homecare settings have gained traction, especially post-pandemic, and currently hold around 20% of the market. The convenience of remote monitoring has been widely appreciated, particularly among the elderly and chronically ill patients who prefer in-home testing. By Technology From a technology standpoint, wearable technologies are transforming the landscape, projected to represent 40% of the market by 2034. These devices offer unmatched convenience and user engagement. Invasive technologies still maintain a solid 45% market share, particularly in clinical environments where precision is critical. Meanwhile, non-invasive technologies are growing steadily and are expected to hold 15% of the market, driven by advancements in optical and sensor-based innovations. By Application Diabetes management remains the top application area, constituting about 50% of the total market. As diabetes rates continue to climb worldwide, the demand for continuous and accurate glucose monitoring devices is increasing proportionally. Cardiovascular monitoring is another important application, making up 30% of the market, while fitness and wellness monitoring is growing rapidly, accounting for around 15% as consumers adopt proactive health strategies. By Distribution Channel In terms of distribution, offline sales still dominate with a 55% market share, primarily due to the preference for in-person consultations and product demonstrations in hospital and clinical settings. Online channels, however, are growing fast and now represent 30% of sales, fueled by digital adoption and e-commerce growth. Direct sales—through specialized distributors—comprise the remaining 15%, ensuring product customization and support services. Browse full Report - Market Segmentation Product Type - Continuous Glucose Monitoring Systems - Blood Pressure Monitoring Devices - Cholesterol Testing Devices - Complete Blood Count Test Devices - Others End-User - Hospitals - Diagnostic Laboratories - Homecare Settings - Research Institutions Technology - Wearable Technology - Non-invasive Technology - Invasive Technology Application - Diabetes Management - Cardiovascular Monitoring - Blood Disorders Management - Fitness and Wellness Monitoring Distribution Channel - Online Sales - Offline Sales - Direct Sales Region - North America - Europe - Asia Pacific - Latin America - Middle East & Africa Regional Outlook Regionally, North America leads the global market, accounting for approximately 40% of total revenues in 2024. This dominance is attributed to advanced healthcare infrastructure, favorable regulatory support, and the presence of leading industry players. Europe follows with a 30% market share, supported by robust public healthcare systems and a rising focus on personalized medicine. The Asia-Pacific region is the fastest-growing market, projected to expand at a CAGR of 7.5%. This growth is driven by large patient populations, increasing disposable income, and government initiatives to enhance healthcare access. Countries such as China, India, and Japan are key contributors to this growth trajectory. Latin America and the Middle East & Africa collectively account for a modest share (5% in 2024) but are poised for steady growth due to improvements in healthcare infrastructure and expanding awareness about chronic disease management. Key Competitors Abbott Laboratories Roche Holding AG Siemens Healthineers Becton, Dickinson and Company (BD) Medtronic plc Nova Biomedical Johnson & Johnson Dexcom, Inc. Arkray, Inc. Ascensia Diabetes Care Terumo Corporation GlySens Incorporated Insulet Corporation Elysium Health LabCorp Recent Industry Developments Several companies have made notable strides in advancing this market: Abbott Laboratories launched FreeStyle Libre 3, a real-time glucose monitor with a discreet sensor, in June 2023, strengthening its lead in the CGM space. In April 2023, Roche formed a strategic partnership with a wearable tech firm to integrate blood monitoring devices with smart devices, enhancing patient engagement and adherence. Siemens Healthineers acquired an AI-based diagnostics company in August 2023, signaling a deeper focus on precision diagnostics through data analytics. Dexcom received FDA approval in September 2023 for a no-fingerstick CGM device, which is likely to broaden its user base and redefine market standards. Medtronic expanded its product line into Asia and Africa in July 2023, targeting underserved markets and accelerating growth in emerging economies. This report is also available in the following languages : Japanese (マルチ血液モニタリングシステム市場), Korean (다혈액 모니터링 시스템 시장), Chinese (多血液监测系统市场), French (Marché des systèmes de surveillance sanguine multi-sang), German (Markt für Multi-Blutüberwachungssysteme), and Italian (Mercato dei sistemi di monitoraggio multi-sangue), etc. Request Sample Pages: More Research Finding – Medical Refrigerated Market The global medical refrigerated market is valued at approximately $6.5 billion in 2024, with projections indicating a potential increase to around $10 billion by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of approximately 4.5% during the forecast period from 2025 to 2034. Cardiovascular Monitoring Devices Market The cardiovascular monitoring devices market is valued at approximately $10.5 billion in 2024, with projections indicating substantial growth, reaching around $16.8 billion by 2034. This translates to a robust Compound Annual Growth Rate (CAGR) of approximately 4.8% during the forecast period from 2025 to 2034. Non Invasive Hemodynamic Detection System Market The global Non-Invasive Hemodynamic Detection System market is valued at approximately USD 2.1 billion in 2024, with strong growth anticipated over the next decade. By 2034, the market is projected to reach around USD 4.5 billion, representing a Compound Annual Growth Rate (CAGR) of approximately 8.0%. Disposable Syringes and Accessories Market The global disposable syringes and accessories market is valued at approximately $7.5 billion in 2024, with a projected growth trajectory that anticipates reaching around $13 billion by 2034. This translates to a compound annual growth rate (CAGR) of about 6.1% over the 2025-2034 period. Blood Collection Mixer Market The blood collection mixer market is valued at approximately $250 million in 2024 and is projected to reach around $400 million by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of about 5.1% during the forecast period from 2025 to 2034. Hemochromatosis Treatment Market The global hemochromatosis treatment market is valued at approximately $2.1 billion in 2024. The market is anticipated to grow significantly, reaching an estimated $3.5 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period of 2025–2034. Gestational Trophoblastic Disease Market The gestational trophoblastic disease (GTD) market is currently valued at approximately $1.8 billion in 2024, with projections indicating a potential growth to around $3.1 billion by 2034. This represents a compound annual growth rate (CAGR) of approximately 6.2% during the forecast period from 2025 to 2034. Septicemia Diagnostic Market The global septicemia diagnostics market is valued at approximately $1.5 billion in 2024, with projections indicating a growth to around $2.9 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of about 7.5% for the period from 2025 to 2034. Single Use Safety Lancet Market The global market for single-use safety lancets, valued at approximately $1.2 billion in 2024, is expected to reach around $2.5 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.7% during the forecast period from 2025 to 2034. Microalbuminuria Test Strip Market The microalbuminuria test strip market is poised for notable growth, valued at approximately $1.2 billion in 2024. This market is projected to expand to around $2.4 billion by 2034, indicating a robust growth trajectory. The Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at 7.3%. Monkeypox Virus Detection Reagent Market The monkeypox virus detection reagent market is anticipated to reach approximately $150 million in value by 2024, driven by heightened awareness and diagnostic needs amid ongoing public health surveillance. The market is projected to expand significantly, reaching an estimated $300 million by 2034, reflecting sustained interest in infectious disease diagnostics and preparedness. Blood Tester Market The global blood testing market is anticipated to reach a value of approximately $75 billion in 2024, driven by increasing prevalence of chronic diseases, rising health awareness, and advancements in diagnostic technologies. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% from 2025 to 2034, potentially reaching over $135 billion by 2034. HBsAg ELISA Test Kit Market The HBsAg ELISA Test Kit market is poised for robust growth, with a current market value estimated at approximately $1.5 billion in 2024. Driven by the increasing global prevalence of Hepatitis B, ongoing advancements in diagnostic technologies, and rising healthcare expenditures, the market is projected to reach around $2.8 billion by 2034. This trajectory indicates a Compound Annual Growth Rate (CAGR) of approximately 6.5% from 2025 to 2034. Blood Plasma Extractor Market The global blood plasma extractor market is valued at approximately $1.2 billion, driven by rising demand for plasma-derived therapies in treating various diseases. The market is projected to reach about $2.9 billion by 2034, reflecting an impressive Compound Annual Growth Rate (CAGR) of approximately 9.2% from 2025 to 2034. Amphetamine Test Kit Market The amphetamine test kit market is projected to reach a value of approximately $500 million in 2024, with expectations to grow to around $900 million by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of 6% during the forecast period of 2025 to 2034. CONTACT: Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Root Beer: Global Market Analysis, Opportunities and Revenue Forecast to 2030 - Growing Popularity of Craft and Premium Root Beer
Root Beer Market Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Root Beer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to Root Beer Market was valued at USD 2024 in 0.98 billion, and is expected to reach USD 1.31 billion by 2030, rising at a CAGR of 4.97%. Its appeal is growing in tandem with rising global consumption of carbonated beverages. Increased demand for flavorful, low-alcoholic drinks, a rising interest among millennials, and the growth of the international foodservice industry are major contributors to this market's growth. Despite a 5% decline in overall U.S. beer production and imports in 2023, the share of small and independent brewers rose to 13.3%, highlighting a shift in consumer preferences toward niche and craft beverages, including root beer. Key Market Drivers: Rising Consumer Preference for Craft SodasThe surge in interest for artisanal and craft beverages is playing a pivotal role in boosting the root beer market. Consumers are gravitating toward more unique, high-quality drink experiences, prompting root beer brands to offer handcrafted, premium products made with natural ingredients and inventive flavor combinations. This movement away from mass-produced soft drinks resonates particularly well with health-conscious and exploratory consumers. Craft root beer manufacturers often emphasize small-batch production, locally sourced ingredients, and sustainable practices - attributes that appeal to younger demographics seeking authenticity and ethical consumption. These characteristics have positioned craft root beer as a standout in the broader beverage market, driving its rising popularity and opening opportunities for new market Market Challenges: Competition from Other Soft Drinks and BeveragesThe root beer market faces strong competition from a wide range of beverage categories including mainstream sodas, energy drinks, flavored waters, teas, and sports beverages. Major global players like Coca-Cola and PepsiCo dominate shelf space and marketing, making it challenging for niche beverages such as root beer to stand out. Additionally, shifting consumer preferences toward healthier drink options - such as low-sugar, plant-based, or functional beverages - are diverting attention from traditional sodas. While root beer retains a loyal customer base, particularly among those who enjoy its distinct flavor, expanding that base is challenging amidst a saturated and health-focused beverage landscape. Root beer brands must focus on innovation, unique flavor profiles, and targeted branding strategies to remain Market Trends: Craft and Premium Root BeerThe growing popularity of craft and premium root beer represents a significant trend shaping the market. These offerings cater to consumer preferences for high-quality, authentic beverages and are typically crafted with all-natural ingredients and minimal processing. They often feature unique and enhanced flavor profiles such as vanilla, spice, or cherry. This trend is particularly popular among millennials and Gen Z, who are drawn to artisanal and small-batch products with a story behind them. The premium positioning of these beverages is further supported by broader interest in the craft beverage movement across sodas, beers, and spirits. As a result, craft root beer is seeing increased shelf space and consumer attention, contributing to ongoing market Market Players Keurig Dr. Pepper Inc. Anheuser-Busch Companies, LLC Blitz-Weinhard Brewing Co. Dad's Root Beer Sprecher Brewing Co. Inc. The Berghoff Bundaberg Brewed Drinks Boylan Bottling Co. Henry Weinhard's Root Beer Jones Soda Co. Report ScopeIn this report, the global Root Beer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Root Beer Market, By Type: Alcoholic Root Beer Non-Alcoholic Root Beer Root Beer Market, By Form: Carbonated Non-carbonated Root Beer Market, By Distribution Channel: Supermarket/ Hypermarket Specialty Stores Online Departmental Stores Others Root Beer Market, By Region: North America Europe Asia-Pacific Middle East & Africa South America Key Attributes Report Attribute Details No. of Pages 189 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $0.98 Billion Forecasted Market Value (USD) by 2030 $1.31 Billion Compound Annual Growth Rate 4.9% Regions Covered Global For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Root Beer Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
